Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Novacyt signs coronavirus test supply contract with UK government

Published 27/04/2020, 07:21
© Reuters. Outbreak of the coronavirus disease (COVID-19) near Frankfurt
ALNOV
-

PARIS (Reuters) - Healthcare and clinical diagnostics company Novacyt (PA:ALNOV) (L:NCYT) has signed a supply contract with the UK's Department of Health & Social Care (DHSC) for its product aimed at testing for the presence of the coronavirus, the company said on Monday.

Under the terms of the agreement, Novacyt will supply its coronavirus test to the DHSC for an initial term of six months, starting from May 4.

© Reuters. Outbreak of the coronavirus disease (COVID-19) near Frankfurt

Novacyt has initially committed to supply 288,000 tests per week to the DHSC for use in the UK's National Health Service, with the option to expand the agreement.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.